This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
John EM , McGuire V , Thomas D , Haile R , Ozcelik H , Milne RL , Felberg A , West DW , Miron A , Knight JA , Terry MB , Daly M , Buys SS , Andrulis IL , Hopper JL , Southey MC , Giles GG , Apicella C , Thorne H , Whittemore AS , Kathleen Cuningham Fdn Consortium
Diagnostic Chest X-Rays and Breast Cancer Risk before Age 50 Years for BRCA1 and BRCA2 Mutation Carriers
Cancer Epidemiology Biomarkers & Prevention. 2013 Sep;22(9) :1547-1556
AbstractBackground: The effects of low-dose medical radiation on breast cancer risk are uncertain, and few studies have included genetically susceptible women, such as those who carry germline BRCA1 and BRCA2 mutations. Methods: We studied 454 BRCA1 and 273 BRCA2 mutation carriers ages younger than 50 years from three breast cancer family registries in the United States, Canada, and Australia/New Zealand. We estimated breast cancer risk associated with diagnostic chest X-rays by comparing mutation carriers with breast cancer (cases) with those without breast cancer (controls). Exposure to chest X-rays was self-reported. Mammograms were not considered in the analysis. Results: After adjusting for known risk factors for breast cancer, the ORs for a history of diagnostic chest X-rays, excluding those for tuberculosis or pneumonia, were 1.16 [95% confidence interval (CI), 0.64-2.11] for BRCA1 mutations carriers and 1.22 (95% CI, 0.62-2.42) for BRCA2 mutations carriers. The OR was statistically elevated for BRCA2 mutation carriers with three to five diagnostic chest X-rays (P = 0.01) but not for those with six or more chest X-rays. Few women reported chest fluoroscopy for tuberculosis or chest X-rays for pneumonia; the OR estimates were elevated, but not statistically significant, for BRCA1 mutation carriers. Conclusions: Our findings do not support a positive association between diagnostic chest X-rays and breast cancer risk before the ages of 50 years for BRCA1 or BRCA2 mutation carriers. Impact: Given the increasing use of diagnostic imaging involving higher ionizing radiation doses, further studies of genetically predisposed women are warranted. (C) 2013 AACR.
NotesJohn, Esther M. McGuire, Valerie Thomas, Duncan Haile, Robert Ozcelik, Hilmi Milne, Roger L. Felberg, Anna West, Dee W. Miron, Alexander Knight, Julia A. Terry, Mary Beth Daly, Mary Buys, Saundra S. Andrulis, Irene L. Hopper, John L. Southey, Melissa C. Giles, Graham G. Apicella, Carmel Thorne, Heather Whittemore, Alice S.